HLI HOULIHAN LOKEY, INC.
Investment Advice · NYSE · SEC CIK 1302215 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.4%
TTM net income YoY-5.4%
TTM EPS YoY-3.7%
Revenue 3-yr CAGR12.7%
Net income 3-yr CAGR17.1%
Margins
Gross margin—
Operating margin20.3%
Net margin15.8%
FCF margin15.7%
EBITDA margin21.6%
Returns
ROE17.7%
ROA10.4%
ROIC (approx.)27.2%
Asset turnover0.66x
Leverage & solvency
Liabilities / assets39.2%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.06x
Accruals ratio-0.6%
Payout ratio46.3%
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 | FY20242024-03-31 | FY20232023-03-31 | FY20222022-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.62B | $2.39B | $1.91B | $1.81B | $2.27B |
| Gross profit | — | $772.31M | $571.07M | $557.08M | $795.29M |
| Operating income | $527.02M | $502.57M | $373.23M | $341.74M | $612.86M |
| Pretax income | $562.26M | $531.34M | $390.54M | $324.00M | $603.94M |
| Income tax | $138.09M | $131.62M | $110.24M | $69.78M | $165.61M |
| Net income | $425.70M | $399.71M | $280.30M | $254.22M | $437.75M |
| EBITDA | $569.65M | $543.84M | $401.77M | $399.96M | $661.40M |
| EPS (basic) | 6.40 | 6.08 | 4.36 | 4.01 | 6.74 |
| EPS (diluted) | 6.22 | 5.82 | 4.11 | 3.76 | 6.41 |
| Weighted avg. shares (diluted) | 68.43M | 68.66M | 68.16M | 67.59M | 68.26M |
| Balance sheet | |||||
| Cash & equivalents | $1.19B | $976.00M | $721.85M | $714.81M | $834.07M |
| PP&E, net | $143.00M | $149.35M | $136.70M | $88.34M | $52.18M |
| Goodwill | $1.40B | $1.28B | $1.13B | $1.09B | $1.07B |
| Total assets | $4.31B | $3.82B | $3.17B | $2.97B | $2.89B |
| Total liabilities | $1.86B | $1.64B | $1.33B | $1.36B | $1.44B |
| Shareholders' equity | $2.34B | $2.17B | $1.84B | $1.61B | $1.44B |
| Cash flow statement | |||||
| Operating cash flow | $704.13M | $848.61M | $328.46M | $136.27M | $736.60M |
| Capital expenditure | $22.31M | $39.70M | $66.73M | $50.73M | $8.68M |
| Free cash flow | $681.82M | $808.91M | $261.73M | $85.54M | $727.92M |
| Investing cash flow | $2.18M | -$265.06M | -$70.41M | -$3.00M | -$273.91M |
| Financing cash flow | -$492.94M | -$329.07M | -$250.59M | -$240.46M | -$459.06M |
| Depreciation & amortization | $42.63M | $41.27M | $28.54M | $58.22M | $48.54M |
| Stock-based compensation | $201.30M | $168.44M | $166.59M | $156.94M | $91.88M |
| Dividends paid | $174.04M | $165.22M | $148.45M | $140.38M | $114.81M |
| Share buybacks | $175.43M | $52.51M | $24.95M | $48.66M | $304.79M |
Free plan shows the latest 5 periods; Pro shows all 13 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.